1887
  1. الرئيسية
  2. A-Z Publications
  3. Journal of Local and Global Health Science
  4. المجلد 2013, العدد 1
  5. المقالة
Volume 2013, Issue 1
  • ISSN: 2223-0440
  • E-ISSN:

ملخص

Arsenic compounds have been known and used for centuries but their effects in living organisms still represent a large unknown. Arsenic compounds have paradoxical effects: they are threatening to human health, especially upon long-term exposure that can induce the development of cancer; however, they are used as drugs against cancer. This review focuses on the effects shown by clinically and environmentally relevant arsenic compounds in living organisms with a focus on the calcium–apoptosis link.

© 2013 Florea, Büsselberg, licensee Bloomsbury Qatar Foundation Journals.
Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/jlghs.2013.1
٢٠١٣-٠٨-٠١
٢٠٢٤-٠٥-٢٠
Loading full text...

Full text loading...

/deliver/fulltext/jlghs/2013/1/jlghs.2013.1.html?itemId=/content/journals/10.5339/jlghs.2013.1&mimeType=html&fmt=ahah

References

  1. Florea AM, Büsselberg D. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals. 2006; 19:4:419–427
     [Google الباحث العلمي]
  2. Florea AM, Büsselberg D. Differential modulation of the intracellular calcium concentration by anti-cancer drugs. Neurotoxicology. 2009 Sep; 30:5:803–810
     [Google الباحث العلمي]
  3. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J. 2003; 79:933:391–396
     [Google الباحث العلمي]
  4. Florea AM. Toxicity of Alkylated Derivatives of Arsenic, Antimony and Tin: Cellular Uptake, Cytotoxicity, Genotoxic Effects, Perturbation of Ca2+ Homeostasis and Cell Death. Aachen: Shaker Verlag 2005;
     [Google الباحث العلمي]
  5. Vahidnia A, van der Voet GB, de Wolff FA. Arsenic neurotoxicity–a review. Hum Exp Toxicol. 2007 Oct; 26:10:823–832
     [Google الباحث العلمي]
  6. Kim KW, Chanpiwat P, Hanh HT, Phan K, Sthiannopkao S. Arsenic geochemistry of groundwater in Southeast Asia. Front Med. 2011 Dec; 5:4:420–433
     [Google الباحث العلمي]
  7. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect. 1999; 107:7:593–597
     [Google الباحث العلمي]
  8. Tchounwou PB, Wilson B, Ishaque A. Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water. Rev Environ Health. 1999; 14:4:211–229
     [Google الباحث العلمي]
  9. Sordo M, Herrera LA, Ostrosky-Wegman P, Rojas E. Cytotoxic and genotoxic effects of As, MMA, and DMA on leukocytes and stimulated human lymphocytes. Teratog Carcinog Mutagen. 2001; 21:4:249–260
     [Google الباحث العلمي]
  10. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodes CJ, Valko M. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol. 2011 Mar;; 31:2:95–107. doi.10.1002/jat.1649
     [Google الباحث العلمي]
  11. Guha Mazumder D, Dasgupta UB. Chronic arsenic toxicity: studies in West Bengal, India. Kaohsiung J Med Sci. 2011 Sep; 27:9:360–370
     [Google الباحث العلمي]
  12. Huang CF, Chen YW, Yang CY, Tsai KS, Yang RS, Liu SH. Arsenic and diabetes: current perspectives. Kaohsiung J Med Sci. 2011 Sep; 27:9:402–410
     [Google الباحث العلمي]
  13. Bolt HM. Arsenic: an ancient toxicant of continuous public health impact, from Iceman Ötzi until now. Arch Toxicol. 2012 Jun; 86:6:825–830, doi: 10.1007/s00204-012-0866-7
     [Google الباحث العلمي]
  14. States JC, Barchowsky A, Cartwright IL, Reichard JF, Futscher BW, Lantz RC. Arsenic toxicology: translating between experimental models and human pathology. Environ Health Perspect. 2011 Oct; 119:10:1356–1363
     [Google الباحث العلمي]
  15. Lan CC, Yu HS, Ko YC. Chronic arsenic exposure and its adverse health effects in Taiwan: a paradigm for management of a global environmental problem. Kaohsiung J Med Sci. 2011 Sep; 27:9:411–416
     [Google الباحث العلمي]
  16. National Research Council. Arsenic in Drinking Water: 2001 Update. Washington, DC: National Academy Press 2001;
     [Google الباحث العلمي]
  17. Florea AM. The anticancer drug arsenic trioxide triggers calcium signaling and induces cell death by apoptosis in tumor and non-tumor cell models. Doctoral Thesis Presented to the Faculty of Medicine, University of Duisburg-Essen, Germany, January 2008
  18. Weider B, Fournier JH. Activation analyses of authenticated hairs of Napoleon Bonaparte confirm arsenic poisoning. Am J Forensic Med Pathol. 1999 Dec; 20:4:378–382
     [Google الباحث العلمي]
  19. Bergstrom SK, Gillan E, Quinn JJ, Altman AJ. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report. J Pediatr Hematol Oncol. 1998; 20:6:545–547
     [Google الباحث العلمي]
  20. Shim MJ, Kim HJ, Yang SJ, Lee IS, Choi HI, Kim T. Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase. J Biochem Mol Biol. 2002; 35:4:377–383
     [Google الباحث العلمي]
  21. Griffin RJ, Williams BW, Park HJ, Song CW. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. Int J Radiat Oncol Biol Phys. 2005; 61:5:1516–1522
     [Google الباحث العلمي]
  22. Breccia M, Lo-Coco F. Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease. Expert Opin Pharmacother. 2012 May; 13:7:1031–1043
     [Google الباحث العلمي]
  23. Mathews V, Chandy M, Srivastava A. Arsenic trioxide in the management of acute promyelocytic leukaemia. Natl Med J India. 2001 Jul-Aug; 14:4:215–222
     [Google الباحث العلمي]
  24. Chen ZY, Liu TP, Yang Y. Manual of Clinical Drugs. Shanghai, China: Shanghai Science and Technology 1995;
     [Google الباحث العلمي]
  25. Zhang TC, Cao EH, Li JF, Ma W, Qin JF. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur J Cancer. 1999; 35:8:1258–1263
     [Google الباحث العلمي]
  26. Du Y, Wang K, Fang H, Li J, Xiao D, Zheng P, Chen Y, Fan H, Pan X, Zhao C, Zhang Q, Imbeaud S, Graudens E, Eveno E, Auffray C, Chen S, Chen Z, Zhang J. Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. Blood. 2006; 107:4:1582–1590
     [Google الباحث العلمي]
  27. Zhang P. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. J Biol Regul Homeost Agents. 1999; 13:4:195–200
     [Google الباحث العلمي]
  28. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997; 89:9:3354–3360
     [Google الباحث العلمي]
  29. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalaycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutré S, Dahlberg S, Ellison R, Warrell RP Jr. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 2001; 19:18:3852–3860
     [Google الباحث العلمي]
  30. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998; 339:19:1341–1348
     [Google الباحث العلمي]
  31. Fenaux P, Chomienne C, Degos L. Treatment of acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2001; 14:1:153–174
     [Google الباحث العلمي]
  32. Zhu J, Chen Z, Lallemand-Breitenbach V, de The H. How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer. 2002; 2:9:705–713
     [Google الباحث العلمي]
  33. Kitchin KT. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol. 2001; 172:3:249–261
     [Google الباحث العلمي]
  34. Goddard MJ, Tanhehco JL, Dau PC. Chronic arsenic poisoning masquerading as Landry-Guillain-Barre syndrome. Electromyogr Clin Neurophysiol. 1992; 32:9:419–423
     [Google الباحث العلمي]
  35. Das NK, Sengupta SR. Arsenicosis: diagnosis and treatment. Indian J Dermatol Venereol Leprol. 2008 Nov-Dec; 74:6:571–581
     [Google الباحث العلمي]
  36. Tournel G, Houssaye C, Humbert L, Dhorne C, Gnemmi V, Bécart-Robert A, Nisse P, Hédouin V, Gosset D, Lhermitte M. Acute arsenic poisoning: clinical, toxicological, histopathological, and forensicfeatures. J Forensic Sci. 2011 Jan; 56 Suppl 1:S275–S279, doi: 10.1111/j.1556-4029.2010.01581.x
     [Google الباحث العلمي]
  37. Guo HR, Chiang HS, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology. 1997; 8:5:545–550
     [Google الباحث العلمي]
  38. Piao F, Ma N, Hiraku Y, Murata M, Oikawa S, Cheng F, Zhong L, Yamauchi T, Kawanishi S, Yokoyama K. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J Occup Health. 2005; 47:5:445–449
     [Google الباحث العلمي]
  39. Florea AM, Yamoah EN, Dopp E. Intracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction. Environ Health Perspect. 2005; 113:6:659–664
     [Google الباحث العلمي]
  40. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997; 28:9:1717–1723
     [Google الباحث العلمي]
  41. Morton WE, Caron GA. Encephalopathy: an uncommon manifestation of workplace arsenic poisoning? Am J Ind Med. 1989; 15:1:1–5
     [Google الباحث العلمي]
  42. Schenk VW, Stolk PJ. Psychosis following arsenic (possibly thallium) poisoning. A clinical-neuropathological report. Psychiatr Neurol Neurochir. 1967; 70:1:31–37
     [Google الباحث العلمي]
  43. Florea AM, Büsselberg D. Toxic effects of metals: use, benefits and toxic cellular effects. Materialwiss. u. Werkstofft. 2005;36:757–760
     [Google الباحث العلمي]
  44. Lee CH, Liao WT, Yu HS. Aberrant immune responses in arsenical skin cancers. Kaohsiung J Med Sci. 2011 Sep; 27:9:396–401
     [Google الباحث العلمي]
  45. Yang HC, Fu HL, Lin YF, Rosen BP. Pathways of arsenic uptake and efflux. Curr Top Membr. 2012; 69::325–358, doi: 10.1016/B978-0-12–39,4390-3.00012-4
     [Google الباحث العلمي]
  46. Qian Y, Castranova V, Shi X. New perspectives in arsenic-induced cell signal transduction. J Inorg Biochem. 2003; 96:2-3:271–278
     [Google الباحث العلمي]
  47. Yang C, Frenkel K. Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis. J Environ Pathol Toxicol Oncol. 2002; 21:4:331–342
     [Google الباحث العلمي]
  48. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A. 1997; 94:20:10907–10912
     [Google الباحث العلمي]
  49. Liao WT, Lan CC, Lee CH, Yu HS. Concentration-dependent cellular responses of arsenic in keratinocytes. Kaohsiung J Med Sci. 2011 Sep; 27:9:390–395
     [Google الباحث العلمي]
  50. Reichard JF, Puga A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics. 2010 Feb; 2:1:87–104
     [Google الباحث العلمي]
  51. Zhang Y, Wu JH, Han F, Huang JM, Shi SY, Gu RD, Chen XL, He B. Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of microRNA-376a. Neoplasma. 2013 Feb; 60:3–253, doi: 10.4149/neo_2013_033
     [Google الباحث العلمي]
  52. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2000; 23:5:222–229
     [Google الباحث العلمي]
  53. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003; 4:7:517–529
     [Google الباحث العلمي]
  54. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003; 4:7:552–565
     [Google الباحث العلمي]
  55. Florea AM, Splettstoesser F, Büsselberg D. Mechanisms of arsenic trioxide (As2O3) induced calcium signals and cellular death in two human SY-5Y Neuroblastoma and 293 embryonic kidney (HEK) cells. TAAP. 2007; 220:May:292–301
     [Google الباحث العلمي]
  56. Florea AM, Büsselberg D. Environmental and clinical relevant concentrations of arsenic trioxide (As2O3) induce calcium signals and and interfere with cell survival of human SY-5Y Neuroblastoma and 293 embryonic kidney (HEK) cells. Toxicol Lett. 2008 June; 179:1:34–42
     [Google الباحث العلمي]
  57. Ferguson C, Kern M, Audesirk G. Nanomolar concentrations of inorganic lead increase Ca2+ efflux and decrease intracellular free Ca2+ ion concentrations in cultured rat hippocampal neurons by a calmodulin-dependent mechanism. Neurotoxicology. 2000; 21:3:365–378
     [Google الباحث العلمي]
  58. Büsselberg D, Platt B, Michael D, Carpenter DO, Haas HL. Mammalian voltage-activated calcium channel currents are blocked by Pb2+, Zn2+, and Al3+ . J Neurophysiol. 1994; 71:4:1491–1497
     [Google الباحث العلمي]
  59. Büsselberg D. Calcium channels as target sites of heavy metals. Toxicol Lett. 1995; 82-83::255–261
     [Google الباحث العلمي]
  60. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol. 2007; 47::143–183
     [Google الباحث العلمي]
  61. Zhivotovsky B, Orrenius S. Carcinogenesis and apoptosis: paradigms and paradoxes. Carcinogenesis. 2006; 27:10:1939–1945
     [Google الباحث العلمي]
  62. Fadeel B, Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med. 2005; 258:6:479–517
     [Google الباحث العلمي]
  63. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998; 281:5381:1309–1312
     [Google الباحث العلمي]
  64. Robertson JD, Orrenius S. Role of mitochondria in toxic cell death. Toxicology. 2002; 181-182::491–496
     [Google الباحث العلمي]
  65. Orrenius S, Zhivotovsky B. The future of toxicology–does it matter how cells die? Chem Res Toxicol. 2006; 19:6:729–733
     [Google الباحث العلمي]
  66. Zimmermann KC, Pinkoski MJ. In the company of killers. Trends Mol Med. 2001; 7:5:195–197
     [Google الباحث العلمي]
  67. Zimmermann KC, Green DR. How cells die: apoptosis pathways. J Allergy Clin Immunol. 2001; 108:4 suppl:S99–103
     [Google الباحث العلمي]
  68. Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell death. Pharmacol Ther. 2001; 92:1:57–70
     [Google الباحث العلمي]
  69. Diaz Z, Colombo M, Mann KK, Su H, Smith KN, Bohle DS, Schipper HM, Miller WH Jr. Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines. Blood. 2005; 105:3:1237–1245
     [Google الباحث العلمي]
  70. Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, Xiao DK, Shen SH, Imbeaud S, Eveno E, Zhao CJ, Chen YL, Fan HY, Waxman S, Auffray C, Jin G, Chen SJ, Chen Z, Zhang J. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005; 102:21:7653–7658
     [Google الباحث العلمي]
  71. Kajiguchi T, Yamamoto K, Hossain K, Akhand AA, Nakashima I, Naoe T, Saito H, Emi N. Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1. Leukemia. 2003; 17:11:2189–2195
     [Google الباحث العلمي]
  72. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. 2002; 62:14:3893–3903
     [Google الباحث العلمي]
  73. Zhou J, Meng R, Sui XH, Lu M, Wang DS, Yang BF. [Effects of protein tyrosine kinase, protein tyrosine phosphatase and protein kinase C on the apoptosis of arsenic trioxide treated NB4 cells and human cortex neurons]. Zhonghua Xue Ye Xue Za Zhi. 2004; 25:10:600–604
     [Google الباحث العلمي]
  74. Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 1994; 54:(7): 1707–1714
     [Google الباحث العلمي]
  75. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004; 149:1-3:19–23
     [Google الباحث العلمي]
  76. Shen ZY, Shen WY, Chen MH, Shen J, Cai WJ, Zeng Y. Mitochondria, calcium and nitric oxide in the apoptotic pathway of esophageal carcinoma cells induced by As2O3 . Int J Mol Med. 2002; 9:4:385–390
     [Google الباحث العلمي]
  77. Zhang P, Wang S, Hu L, Qiu F, Yang H, Xiao Y, Li X, Han X, Zhou J, Liu P. [Seven years' summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide-an analysis of 242 cases]. Zhonghua Xue Ye Xue Za Zhi. 2000; 21:2:67–70
     [Google الباحث العلمي]
  78. Davison K, Mann KK, Waxman S, Miller WH Jr. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells. Blood. 2004; 103:9:3496–3502
     [Google الباحث العلمي]
  79. Nutt LK, Gogvadze V, Uthaisang W, Mirnikjoo B, McConkey DJ, Orrenius S. Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis. Cancer Biol Ther. 2005; 4:4:459–467
     [Google الباحث العلمي]
  80. Bustamante J, Nutt L, Orrenius S, Gogvadze V. Arsenic stimulates release of cytochrome c from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol Appl Pharmacol. 2005; 207:2 suppl:110–116
     [Google الباحث العلمي]
  81. Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 1999; 6:6:516–524
     [Google الباحث العلمي]
  82. Ora I, Bondesson L, Jönsson C, Ljungberg J, Pörn-Ares I, Garwicz S, Pâhlman S. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro . Biochem.Biophys.Res.Commun. 2000; 277::179–185
     [Google الباحث العلمي]
  83. Wei YM, Ou YX, Bai H, Lu JH, Zheng RL. Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines. Acta Pharmacol Sin. 2001; 22:8:725–730
     [Google الباحث العلمي]
  84. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V, Shi X. Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem. 2001a; 276:14:11414–11419
     [Google الباحث العلمي]
  85. Chen Z, Chen GQ, Shen ZX, Chen SJ, Wang ZY. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies. Semin Hematol. 2001b; 38:1:26–36
     [Google الباحث العلمي]
  86. Verma A, Mohindru M, Deb DK, Sassano A, Kambhampati S, Ravandi F, Minucci S, Kalvakolanu DV, Platanias LC. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide. J Biol Chem. 2002; 277:47:44988–44995
     [Google الباحث العلمي]
  87. Haga N, Fujita N, Tsuruo T. Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells. Cancer Sci. 2005; 96:11:825–833
     [Google الباحث العلمي]
  88. Chun YJ, Park IC, Park MJ, Woo SH, Hong SI, Chung HY, Kim TH, Lee YS, Rhee CH, Lee SJ. Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3). FEBS Lett. 2002; 519:1-3:195–200
     [Google الباحث العلمي]
  89. Lindskog M, Gleissman H, Ponthan F, Castro J, Kogner P, Johnsen JI. Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress. Int J Cancer. 2006; 118:10:2584–2593
     [Google الباحث العلمي]
  90. Cheung WM, Chu PW, Kwong YL. Effects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cells. Cancer Letters. 2007; 246:1-2:122–128
     [Google الباحث العلمي]
  91. Du YH, Ho PC. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines. Cancer Chemother Pharmacol. 2001; 47:6:481–490
     [Google الباحث العلمي]
  92. Kim S, Takeuchi A, Kawasumi Y, Endo Y, Lee H, Kim Y. A Guillain-Barré Syndrome-like Neuropathy Associated with Arsenic Exposure. J Occup Health. 2013; 31:54:(4):344–347
     [Google الباحث العلمي]
http://instance.metastore.ingenta.com/content/journals/10.5339/jlghs.2013.1
Loading
  • نوع المستند: Research Article

الأكثر اقتباسًا لهذا الشهر Most Cited RSS feed

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error